The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 15,701–15,800 of 31,469
Bahijri, S., Alsheikh, L., Ajabnoor, G., & Borai, A. (2017) · Nutrition and Metabolic Insights · doi:10.1177/1178638817710666 · Cited by 19
Sabater, A. G., Ribot, J., Priego, T., Vazquez, I., Frank, S., Palou, A., & Buchwald‐Werner, S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477606 · Cited by 19
Metabolic syndrome in Egyptian patients with vitiligo
Sallam, M., Gaballah, M. A., State, A. F., et al. (2017) · Journal of the Egyptian Womenʼs Dermatologic Society · doi:10.1097/01.ewx.0000513078.01555.d6 · Cited by 19
Garbacz, W. G., Jiang, M., Xu, M., Yamauchi, J., Dong, H. H., & Xie, W. (2017) · Endocrinology · doi:10.1210/en.2017-00571 · Cited by 19
Kim, G., Lee, Y.-H., Yun, M. R., Lee, J.-Y., Shin, E., Lee, B.-W., Kang, E. S., & Cha, B.-S. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.222 · Cited by 21
Serum Irisin levels as a marker in some phenotypes of PCOS
Foda, A. A., Foda, E. A., & Aal, I. A. A. (2017) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2017.09.005 · Cited by 19
Impact of body fat percentage change on future diabetes in subjects with normal glucose tolerance
Zhao, T., Lin, Z., Zhu, H., Wang, C., & Jia, W. (2017) · IUBMB Life · doi:10.1002/iub.1693 · Cited by 19
Zhou, M., Pan, Y., Jing, J., et al. (2017) · European Journal of Neurology · doi:10.1111/ene.13546 · Cited by 19
Increased serum neuregulin 4 levels in women with polycystic ovary syndrome: A case-control study
Temür, M., Çalan, M., Akşit, M., Yılmaz, Ö., Çift, T., Akselim, B., Çakmak, B. D., & Üstünyurt, E. (2017) · Ginekologia Polska · doi:10.5603/gp.a2017.0095 · Cited by 19
de Beires, T. S., Silva‐Pinto, A., Santos, A. C., Madureira, A. J., Pereira, J., Carvalho, D. M., Sarmento, A., & Freitas, P. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-017-2884-9 · Cited by 19
Jeon, J. Y., Lee, S. J., Lee, S., Kim, S. J., Han, S. J., Kim, H. J., Kim, D. J., Kim, Y. S., Woo, J., Ahn, K. J., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12801 · Cited by 19
Four Plasma Glucose and Insulin Responses to a 75 g OGTT in Healthy Young Japanese Women
Takahashi, K., Nakamura, H., Sato, H., Matsuda, H., Takada, K., & Tsuji, T. (2018) · Journal of Diabetes Research · doi:10.1155/2018/5742497 · Cited by 19
Alves‐Santos, N. H., Cocate, P. G., Eshriqui, I., Benaim, C., Barros, É. G., Emmett, P. M., & Kac, G. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114517003580 · Cited by 20
Mercier, R., Perron, J., Weisnagel, S. J., & Robitaille, J. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1669-2 · Cited by 21
Danchun, L., Xu, N., Sun, J., Li, Z., Liao, R., Zhang, H., Liang, X., & Wei, Y. (2018) · Acupuncture in Medicine · doi:10.1136/acupmed-2016-011253 · Cited by 19
Jia, A., Xu, S., Ming, J., Xing, Y., Guo, J., Zhao, M., Zhang, L., & Ji, Q. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0107-0 · Cited by 20
Spiller, S., Li, Y., Blüher, M., Welch, L. R., & Hoffmann, R. (2018) · Pharmaceuticals · doi:10.3390/ph11020038 · Cited by 19
Low fasting serum insulin and dementia in nondiabetic women followed for 34 years
Mehlig, K., Lapidus, L., Thelle, D. S., Wærn, M., Zetterberg, H., Björkelund, C., Skoog, I. G., & Lissner, L. (2018) · Neurology · doi:10.1212/wnl.0000000000005911 · Cited by 19
Friedman, D. N., Hilden, P. D., Moskowitz, C. S., Wolden, S. L., Tonorezos, E. S., Antal, Z., Carlow, D. C., Modak, S. I., Cheung, N. V., Oeffinger, K. C., et al. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27304 · Cited by 19
Caro-Gomez, M. A., Naranjo-González, C. A., Gallego-Lopera, N., Parra, M. V., Valencia, D. M., Arcos, E. G., Perrasse, A. V., & Bedoya‐Berrío, G. (2018) · Gene · doi:10.1016/j.gene.2018.07.066 · Cited by 21
Genovesi, S., Orlando, A., Rebora, P., Giussani, M., Antolini, L., Nava, E., Parati, G., & Valsecchi, M. G. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy096 · Cited by 21
Huang, X., Wu, D., Cheng, Y., Zhang, X., Liu, T., Liu, Q., Xia, P., Zhang, G., Hu, S., & Liu, S. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12948 · Cited by 17
Bailetti, D., Bertoccini, L., Mancina, R. M., Barchetta, I., Capoccia, D., Cossu, E., Pujia, A., Lenzi, A., Leonetti, F., Cavallo, M. G., et al. (2018) · Obesity Science & Practice · doi:10.1002/osp4.311 · Cited by 19
Xu, Y., Ma, X., Pan, X., He, X., Wang, Y., & Bao, Y. (2018) · Liver International · doi:10.1111/liv.14021 · Cited by 19
Alasqah, M. N., Al‐Shibani, N., Al‐Aali, K. A., et al. (2018) · Clinical Implant Dentistry and Related Research · doi:10.1111/cid.12700 · Cited by 19
Ueland, T., Michelsen, A. E., Aukrust, P., Henriksen, T., Bollerslev, J., & Lekva, T. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3114 · Cited by 19
Papandreou, C., Camacho‐Barcia, L., García-Gavilán, J. F., Hansen, T. T., Hjorth, M. F., Halford, J. C. G., Salas‐Salvadó, J., Sjödin, A. M., & Bulló, M. (2019) · SLEEP · doi:10.1093/sleep/zsz030 · Cited by 21
Zhu, C., Mei, F., Gao, J., Zhou, D., Lu, L., & Qu, S. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14783 · Cited by 19
Nakajima, I., Kojima, M., Oe, M., Ojima, K., Muroya, S., & CHIKUNI, K. (2019) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2019.01.002 · Cited by 19
Ichikawa, T., Miyaaki, H., Miuma, S., et al. (2019) · Biomedical Reports · doi:10.3892/br.2019.1189 · Cited by 19
Huang, J., Qin, S., Huang, L., Tang, Y., Ren, H., & Hu, H. (2019) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12648 · Cited by 20
Bhattacharyya, S., Feferman, L., & Tobacman, J. K. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9582714 · Cited by 21
The association between lecithin–cholesterol acyltransferase activity and fatty liver index
Janać, J., Zeljković, A., Jelić‐Ivanović, Z., Dimitrijevic-Sreckovic, V. S., Miljković, M., Stefanović, A., Munjas, J., Vekić, J., Kotur‐Stevuljević, J., & Spasojević‐Kalimanovska, V. (2019) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563219853596 · Cited by 19
Whole‐body vibration for patients with nonalcoholic fatty liver disease: a 6‐month prospective study
Oh, S., Oshida, N., Someya, N., Maruyama, T., Isobe, T., Okamoto, Y., Kim, T., Kim, B., & Shoda, J. (2019) · Physiological Reports · doi:10.14814/phy2.14062 · Cited by 20
Barchuk, M., Schreier, L. E., Lopez, G. I., Cevey, Á. C., Baldi, J., Tome, M. C. F., Goren, N., Rubio, M., Miksztowicz, V., & Berg, G. A. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.06.915 · Cited by 19
Luo, K., Wang, X., & Zhang, G. (2019) · Food & Function · doi:10.1039/c9fo00798a · Cited by 19
Cortés, Y. I., Catov, J. M., Brooks, M. M., Khoudary, S. R. E., Thurston, R. C., Matthews, K. A., Isasi, C. R., Jackson, E. A., & Barinas‐Mitchell, E. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.07.012 · Cited by 19
Karimian, N., Kaneva, P. A., Donatelli, F., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003488 · Cited by 19
Frigati, L. J., Brown, K. L., Mahtab, S., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25386 · Cited by 19
Randrianarisoa, E., Lehn‐Stefan, A., Krier, J., Böhm, A., Heni, M., de Angelis, M. H., Fritsche, A., Häring, H., Stefan, N., & Staiger, H. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz020 · Cited by 19
Aslanıpour, B., Alan, M., & Demir, İ. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1665646 · Cited by 19
Yau, M., Chacko, E., Regelmann, M. O., Annunziato, R. A., Wallach, E., Chia, D. J., & Rapaport, R. (2019) · Hormone Research in Paediatrics · doi:10.1159/000502308 · Cited by 19
Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus in a Semi-Urban Brazilian Population
Moreira, N. C. D. V., Montenegro, R. M., Meyer, H. E., Bhowmik, B., Mdala, I., Siddiquee, T., Fernandes, V. O., & Hussain, A. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193598 · Cited by 19
α-lipoic acid in patients with autosomal dominant polycystic kidney disease
Lai, S., Petramala, L., Muscaritoli, M., Cianci, R., Mazzaferro, S., Mitterhofer, A. P., Pasquali, M., D’Ambrosio, V., Carta, M., Ansuini, M., et al. (2019) · Nutrition · doi:10.1016/j.nut.2019.110594 · Cited by 20
Baghbani‐Oskouei, A., Tohidi, M., Hasheminia, M., Azizi, F., & Hadaegh, F. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0402-3 · Cited by 18
Özkul, Ö., Çefle, A., Yazici, A., Karadağ, D. T., Işık, Ö. Ö., Tekeoğlu, S., & Aktürk, A. Ş. (2019) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2019.19029 · Cited by 19
High-Sensitivity C-Reactive Protein Is Associated with Prediabetes and Adiposity in Korean Youth
Shin, S. H., Lee, Y. J., Lee, Y. A., Kim, J. H., Lee, S. Y., & Shin, C. H. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0076 · Cited by 20
Flores-Viveros, K. L., Aguilar-Galarza, B. A., Ordóñez-Sánchez, M. L., et al. (2019) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2019.10.012 · Cited by 19
Fatima, F., Ahsan, N., Nasim, A., & Alam, F. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.2.1106 · Cited by 19
Lim, S. K., Ku, E. J., Lee, S. Y., Lee, J. H., Lee, J.-E., Kim, K. M., & Davies, M. J. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000807 · Cited by 19
Sun, Y. X., Zhu, M., Zhao, H., Ni, X., Chang, R., Su, J., Huang, H., Cui, S., Wang, X., Yuan, J., et al. (2020) · BioMed Research International · doi:10.1155/2020/1751989 · Cited by 19
Yu, L. J., Feng, D., Esangbedo, I. C., Zhao, Y., Han, L., Zhu, Y., Fu, J., Li, G., Wang, D., Wang, Y., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000724 · Cited by 21
Sung, H. H., Park, C.-E., Gi, M. Y., Cha, J. A., Moon, A. E., Kang, J. K., Seong, J.-M., Lee, J. H., & Yoon, H. J. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0517 · Cited by 20
Serum irisin levels as a potential marker for diagnosis of gestational diabetes mellitus.
Al-Ghazali, M. J., Ali, H. A., & Al-Rufaie, M. M. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i1.7675 · Cited by 19
Prevalence of vitamin D deficiency in urban south Indians with different grades of glucose tolerance
Jayashri, R., Venkatesan, U., Shanthirani, C. S., Deepa, M., Anjana, R. M., Mohan, V., & Pradeepa, R. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520001129 · Cited by 19
Pérez‐Gimeno, G., Rupérez, A. I., Vázquez‐Cobela, R., Gastesi, G. H., Gil‐Campos, M., Aguilera, C. M., Moreno, L. A., Leis, R., & Bueno, G. (2020) · Nutrients · doi:10.3390/nu12041027 · Cited by 20
Lighter serum copper isotopic composition in patients with early non-alcoholic fatty liver disease
Campenhout, S. V., Hastuti, A. A. M. B., Lefere, S., et al. (2020) · BMC Research Notes · doi:10.1186/s13104-020-05069-3 · Cited by 19
Fernández‐Verdejo, R., Castro‐Sepúlveda, M., Gutiérrez‐Pino, J., Malo‐Vintimilla, L., López‐Fuenzalida, A., Olmos, P. R., Santos, J. L., & Galgani, J. E. (2020) · Obesity · doi:10.1002/oby.22783 · Cited by 20
Arunsak, B., Pratchayasakul, W., Amput, P., Chattipakorn, K., Tosukhowong, T., Kerdphoo, S., Jaiwongkum, T., Thonusin, C., Palee, S., Chattipakorn, N., et al. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108470 · Cited by 19
Mert, H., İrak, K., ÇİBUK, S., Yıldırım, S., & Mert, N. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1781900 · Cited by 19
Damen, L., Grootjen, L. N., Donze, S., Juriaans, A. F., de Graaff, L. C. G., van der Velden, J. A. E. M., & Hokken‐Koelega, A. C. S. (2020) · Clinical Endocrinology · doi:10.1111/cen.14274 · Cited by 19
Yang, N. Y., He, L., Li, Y., et al. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s257884 · Cited by 19
Mendelian Randomization Study: The Association Between Metabolic Pathways and Colorectal Cancer Risk
Jung, S. Y., Papp, J. C., Sobel, E. M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01005 · Cited by 19
Romo-Romo, A., Aguilar-Salinas, C. A., López-Carrasco, M. G., Guillén-Pineda, L. E., Brito-Córdova, G. X., Gómez-Díaz, R. A., Gomez-Perez, F. J., & Almeda‐Valdés, P. (2020) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2020.03.018 · Cited by 19
Ahn, N., & Kim, K. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17165910 · Cited by 22
Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms
Wang, J., Zhang, Y., Liu, Z., Yang, Y., Zhong, Y., Ning, X., Zhang, Y., Zhao, T., Xia, L., Geng, F., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02809-4 · Cited by 19
Celestrin, C. P., Rocha, G. Z., Stein, A. M., Guadagnini, D., Tadelle, R. M., Saad, M. J. A., & Oliveira, A. G. (2020) · European Review of Aging and Physical Activity · doi:10.1186/s11556-020-00244-8 · Cited by 22
Makena, W., Hambolu, J. O., Timbuak, J. A., Umana, U. E., Iliya, A. I., & Dibal, N. I. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00648-4 · Cited by 19
Ho, J. H., Ong, K. L., Torres, L., Liu, Y., Adam, S., Iqbal, Z., Dhage, S. S., Ammori, B. J., Syed, A. A., Rye, K., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000963 · Cited by 20
Yuan, T., Liu, S., Dong, Y., Fu, Y., Tang, Y., & Zhao, W. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00600-9 · Cited by 19
Benhalima, K., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa831 · Cited by 22
Association between low muscle mass and metabolic syndrome in elderly Japanese women
Nomura, K., Eto, M., Ogawa, S., Kojima, T., Iijima, K., Nakamura, T., Araki, A., Ouchi, Y., & Akishita, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243242 · Cited by 19
Mily, A., Sarker, P., Taznin, I., Hossain, D., Haq, M. A., Kamal, S. M. M., Agerberth, B., Brighenti, S., & Raqib, R. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05473-x · Cited by 20
Chatterjee, A., Basu, A., Das, K., Chowdhury, A., & Basu, P. (2021) · Gene · doi:10.1016/j.gene.2021.145431 · Cited by 20
Andrisse, S., Garcia‐Reyes, Y., Pyle, L. L., Kelsey, M. M., Nadeau, K. J., & Cree‐Green, M. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab008 · Cited by 20
Tian, L., Ri, H.-P., Qi, J., & Fu, P. (2021) · Molecular Pain · doi:10.1177/1744806921996101 · Cited by 19
RetractedErdős, B., van Sloun, B., Adriaens, M., O'Donovan, S. D., Langin, D., Astrup, A., Blaak, E., Arts, I., & van Riel, N. (2021) · PLoS Comput. Biol. · doi:10.1371/journal.pcbi.1008852 · Cited by 16
Yoshinari, M., Hirakawa, Y., Hata, J., Higashioka, M., Honda, T., Yoshida, D., Mukai, N., Nakamura, U., Kitazono, T., & Ninomiya, T. (2021) · Diabetologia · doi:10.1007/s00125-021-05459-7 · Cited by 20
Kang, M. K., & Park, J.-G. (2021) · Diagnostics · doi:10.3390/diagnostics11050854 · Cited by 20
The effect of Thyroid Autoimmunity on Dyslipidemia in patients with Euthyroid Hashimoto Thyroiditis
Cengiz, H., Demirci, T., Varım, C., & Tamer, A. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.5.3883 · Cited by 23
Fat mass and obesity-associated gene expression and disease severity in type 2 diabetes mellitus
Gayed, E. M. A. E., Zewain, S. K., Ragheb, A., & El-Naidany, S. S. (2021) · Steroids · doi:10.1016/j.steroids.2021.108897 · Cited by 23
Ruze, R., Xu, Q., Liu, G., Li, Y., Chen, W., Cheng, Z., Xiong, Y., Liu, S., Zhang, G., Hu, S., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00126.2021 · Cited by 20
Anti-obesity effect of Cydonia oblonga Miller extract in high-fat diet-induced obese C57BL/6 mice
Lee, H. S., Jeon, Y. E., Jung, J. I., Kim, S. M., Hong, S. H., Lee, J., Hwang, J. S., Hwang, M. O., Kwon, K., & Kim, E. J. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104945 · Cited by 19
Costa, Y. C., Mauro, V. M., Fairman, E. B., Charask, A. A., Olguín, L., Cáceres, L., & Barrero, C. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101112 · Cited by 19
Chang, T.-Y., Wu, C., Chang, C., Lee, F., Wang, B.-W., Doong, J.-Y., Lin, Y., Kuo, C.-S., & Huang, R.-F. S. (2022) · Nutrients · doi:10.3390/nu14020261 · Cited by 20
Zhu, C., Ma, H., Huang, D., Li, G., Gao, J., Cai, M., You, H., Bu, L., & Qu, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.815995 · Cited by 20
Birck, M. G., de Almeida-Pititto, B., Janovsky, C. C. P. S., Goulart, A. C., Santos, I. S., Teixeira, P. D. F. D. S., Sgarbi, J. A., Barreto, S. M., Duncan, B. B., Schmidt, M. I., et al. (2022) · Thyroid · doi:10.1089/thy.2021.0533 · Cited by 20
FABP4 plasma levels are increased in familial combined hyperlipidemia
Cabré, A., Lázaro, I., Cofán, M., Jarauta, E., Plana, N., García-Otín, A. L., Ascaso, J. F., Ferré, R., Civeira, F., Ros, E., et al. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m900066-jlr200 · Cited by 19
Circulating retinol-binding protein 4 and metabolic syndrome in the elderly
Mostafaie, N., Sebesta, C., Zehetmayer, S., Jungwirth, S., Huber, K. R., Hinterberger, M., Leitha, T., Hofman, J., Hejtman, M., Schrattbauer, K., et al. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0885-7 · Cited by 19
Leelaphiwat, S., Jongwutiwes, T., Lertvikool, S., Tabcharoen, C., Sukprasert, M., Rattanasiri, S., & Weerakiet, S. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12543 · Cited by 19
Maximal Fat Oxidation Rate during Exercise in Korean Women with Type 2 Diabetes Mellitus
Suk, M. H., Moon, Y.-J., Park, S. W., Park, C., & Shin, Y. A. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.328 · Cited by 20
Clapauch, R., Mourão, A. F., Mecenas, A. S., Maranhao, P. A., Rossini, A., & Bouskela, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103444 · Cited by 19
Russo, G. T., Horvath, K. V., Benedetto, A. D., Giandalia, A., Cucinotta, D., & Asztalos, B. F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.011 · Cited by 19
Relationship Between Lipid Abnormalities and Insulin Resistance in Japanese School Children
Asato, Y., Katsuren, K., Ohshiro, T., Kikawa, K., Shimabukuro, T., & Ohta, T. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000245804.56871.31 · Cited by 19
Leukotriene Production Is Increased in Abdominal Obesity
Bäck, M., Avignon, A., Stanke‐Labesque, F., Boegner, C., Attalin, V., Leprieur, E., & Sultan, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104593 · Cited by 19
Ning, F., Qiao, Q., Tuomilehto, J. O., Hammar, N., Ho, S. Y., Söderberg, S., Zimmet, P., Shaw, J. E., Nakagami, T., Mohan, V., et al. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1078 · Cited by 19
Derosa, G., D’Angelo, A., Fogari, E., et al. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0320 · Cited by 19
Zeman, M., Vecka, M., Jáchymová, M., Jirák, R., TVRZICKÁ, E., Staňková, B., & Žák, A. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.217.287 · Cited by 19
Hirota, Y., Ohara, T., Zenibayashi, M., Kuno, S., Fukuyama, K., Teranishi, T., Kouyama, K., Miyake, K., Maeda, E., & Kasuga, M. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.014 · Cited by 19
SIMONE, G. D., Devereux, R. B., Palmieri, V., Roman, M., Celentano, A., Welty, T. K., Fabsitz, R. R., Contaldo, F., & Howard, B. V. (2003) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(03)80173-4 · Cited by 19
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
